More New Yorkers are getting life-saving colonoscopies than ever before, the Health Department announced today, and people of all races and incomes are benefiting. The test ? which can detect, prevent, or cure colorectal cancer ? is generally recommended once every decade for people 50 and older, and earlier for those with a family history of the disease.
Researchers at the Stanford University School of Medicine have identified the cancer stem cells that propagate tumors in colon and rectal cancer, a discovery that could lead to improved treatment of this deadly cancer.
Physiological differences between men and women may contribute to differential tumor development and progression in colon cancer patients, a study led by researchers at the University of Southern California (USC) suggests.
A new technique called “microarrays” was used in this study, which enables the identification of the specific effects produced by drugs on each human gene. The study, conducted in the Department of Human Anatomy and Embryology at the University of Granada, looked at six new compounds which reduce the side effects of cancer treatment. Results available in Tetrahedron.
A new study showing a reduction in the toxic side effects of ROS-generating chemotherapies with concurrent antioxidant supplementation will be presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) that takes place June 1-5 at McCormick Place in Chicago.
Although the colonoscopy is considered the most effective means to detect precursors of colon cancer, the overall reported rate of missing colorectal tumors is 24 percent, as reported in 1997.
As more and more people rely on colonoscopies for the prevention and early detection of colon cancer, it is crucial that researchers assess the process quality of colonoscopies and identify factors associated with poor quality, specifically in outpatient colonoscopies.
Colonoscopies are considered the gold standard for detecting colon cancer, the second leading cause of cancer deaths in the United States. Research presented today at Digestive Disease Week 2007 discusses contributing factors that could prevent patients from getting optimal results from their colonoscopy, including age of the patient, location of the screening and proper technician training.
To prevent colon cancer, the second leading cause of United States cancer deaths, the American Cancer Society recommends that after age 50 people undergo colonoscopies every ten years to detect signs of that disease ? either actual tumors or precancerous polyps.
A colon cancer researcher at the Ireland Cancer Center of University Hospitals Case Medical Center (UHCMC) has laid out the roadmap for how medical science should employ aspirin and new aspirin-like drugs for use in preventing colon cancer in certain high-risk individuals.